This inventor holds 1 USPTO granted patent, plus 1 CIPO patent. Top assignee: Qilu Pharmaceutical Co., Ltd.. Active years: 2020.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Company Filing History:
Years Active: 2020
Title: Long Li - Innovator in Pharmaceutical Compounds
Introduction
Long Li is a notable inventor based in Shandong, China. He has made significant contributions to the field of pharmaceuticals, particularly in the development of novel compounds. His work focuses on enhancing the efficacy and usability of pharmaceutical formulations.
Latest Patents
Long Li holds a patent for a polymorphic form of a compound, specifically methyl (3R,6S)-6-amino-sulfonylamino-1-(thiazol-2-yl)-3-(2,3,4-trifluorophenyl)-3,5,6,7-tetrahydropyrrolo[1,2-c]pyrimidin-4-formate. This patent encompasses the preparation method and various uses of the compound. The disclosure also includes a pharmaceutical composition and the preparation method of the polymorphic forms of this compound.
Career Highlights
Long Li is currently associated with Qilu Pharmaceutical Co., Ltd., where he continues to innovate in the pharmaceutical sector. His expertise in compound formulation has positioned him as a valuable asset in his field.
Collaborations
He has collaborated with notable colleagues such as Jianwei Shen and Jin Zhang, contributing to various projects that enhance the pharmaceutical landscape.
Conclusion
Long Li's work in developing polymorphic forms of pharmaceutical compounds showcases his dedication to innovation in the field. His contributions are vital for advancing pharmaceutical applications and improving patient outcomes.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile